Iht Wealth Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Iht Wealth Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $17,116 - $70,910	-61,130 Reduced 80.49%	14,820 $4,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $508 - $801	480 Added 0.64%	75,950 $88,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $849 - $1,206	-674 Reduced 0.89%	75,470 $127,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $674 - $1,064	419 Added 0.55%	76,144 $137,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $26,510 - $45,347	23,255 Added 44.32%	75,725 $140,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $4,770 - $8,705	3,975 Added 8.2%	52,470 $69,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $5,297 - $11,440	-3,250 Reduced 6.28%	48,495 $81,000
Q3 2022 Nov 22, 2022	BUY	$0.73 - $3.74 $3,850 - $19,728	5,275 Added 11.35%	51,745 $161,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $102,234 - $195,174	46,470 New	46,470 $111,000
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $31,079 - $95,433	-10,982 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $91,260 - $163,851	10,982 New	10,982 $91,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.